Bitcoin (BTCUSD) climbed as high as $124,200 on August 14, touching another record high as investors embraced riskier assets amid…
Read More »Quantum BioPharma
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is doubling down on two fronts—market advocacy and product expansion. This week,…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is making headlines in April, launching its innovative alcohol detox drink, unbuzzd™,…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is riding a wave of optimism following robust financial improvements, promising clinical…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) isn’t standing still. The biopharmaceutical innovator behind the clinically validated…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced the completion of its clinical trial titled: “A Phase…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), a biopharmaceutical company dedicated to building a portfolio of innovative…
Read More »
Shares of Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), an up-and-coming biotech stock with a tiny float,…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced that its licensee, Celly Nutrition, the company behind unbuzzd™, the…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced today the completion of its double-blind, randomized, placebo-controlled crossover…
Read More »